N.B.: This evaluation refers to 2020 and is outdated: display the current evaluation.

INTARCIA THERAPEUTICS INC

United States of America (US)

OpenCorporation rating: 7.57 on 100

Ranking 2020: 568 on 602 companies


Primary and secondary NACE classification:
• Manufacture of pharmaceutical preparations (2120)
• Manufacture of pharmaceutical preparations (2120)

Company description

This company is engaged in developing innovative therapies utilizing the Medici Drug Delivery System - medicines that have the potential to transform the prevention and management of serious chronic diseases. It has its registered head office located in Boston, Massachusetts, United States. The company's novel technology platform, the Medici Drug Delivery System, comprised of three unique technologies: a stabilization technology that allows for proteins, peptides, antibody fragments, and other highly potent small molecules to be stabilized at or above human body temperatures for up to three years or more; a matchstick-sized osmotic mini-pump that is placed just under the dermal layer of skin to deliver a continuous and consistent flow of medication; and a placement technology including proprietary tools designed to provide an optimal user experience. The therapies it develops: are based on promising therapeutic classes with proven clinical safety and activity; hold potential to represent significant improvements over the established standards of care; may qualify for accelerated development and regulatory pathways; and create proprietary product candidates, securing or extending exclusivity.

[…] show more

OpenCorporation questionnaire

The read only version of the questionnaire submitted to this company is publicly available: view questionnaire.

Indicators

The rating is calculated on the following metrics (for more information visit the section Methodology).

score (max is 100)
15
8.7
0
0
0
0
21
0
13.7

HQ and subsidiaries

INTARCIA THERAPEUTICS INC
loading subsidiaries

* The position of map pins may not reflect the exact location

About this evaluation

This company did not compile the OpenCorporation questionnaire, for this reason this evaluation was made only on data available to the project staff.

Claims and support from the company

If as a company manager or official of INTARCIA THERAPEUTICS INC you want to enter in touch with our staff, provide more information to OpenCorporation or get an account to access and compile the company questionnaire, please write an email to support@opencorporation.org.

Tell the OpenCorporation team

If you detect corporate behavior in contrast with what emerges from the OpenCorporation corporate rating card in your country, or in the branch where you work, report it to info@opencorporation.org so that our team can take it in account.

More evaluations

This company has other evaluations:

Permament links

The link below will always open the 2020 evaluation:

2020: https://www.opencorporation.org/en/ranking/intarcia-therapeutics-inc/2020    url copied

The link below will always open the latest evaluation available:

Last: https://www.opencorporation.org/en/ranking/intarcia-therapeutics-inc/last    url copied